Form 8-K - Current report:
SEC Accession No. 0001104659-26-077820
Filing Date
2026-06-25
Accepted
2026-06-25 17:00:40
Documents
11
Period of Report
2026-06-24
Items
Item 5.07: Submission of Matters to a Vote of Security Holders

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm2618851d1_8k.htm   iXBRL 8-K 33609
  Complete submission text file 0001104659-26-077820.txt   201160

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA ganx-20260624.xsd EX-101.SCH 3038
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE ganx-20260624_lab.xml EX-101.LAB 34239
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE ganx-20260624_pre.xml EX-101.PRE 22374
14 EXTRACTED XBRL INSTANCE DOCUMENT tm2618851d1_8k_htm.xml XML 3318
Mailing Address 4800 HAMPDEN LANE SUITE 200 BETHESDA MD 20814
Business Address 4800 HAMPDEN LANE SUITE 200 BETHESDA MD 20814 (301) 500-1556
Gain Therapeutics, Inc. (Filer) CIK: 0001819411 (see all company filings)

EIN.: 851726310 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-40237 | Film No.: 261122851
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)